Company intelligence / Profile preview

Clinical AI

Ownership: Private
Development stage: Commercial

Overview

Clinical AI offers the MAIA™ platform, an advanced artificial intelligence solution designed to streamline and automate various aspects of clinical research and healthcare delivery. The platform supports functions such as patient prescreening for trials, language translation services in medical contexts, real-world evidence generation from data sources, insurance billing automation, chatbot support for patients/providers, and data reconciliation. There are no published clinical results in the sense of therapeutic efficacy since it is a software/platform company rather than a therapeutics developer [1].

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Clinical AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinical AI.

Explore the full profile